Literature DB >> 9088863

Effects of combined chronic nimodipine and acute metrifonate treatment on spatial and avoidance behavior.

M Riekkinen1, B Schmidt, J Kuitunen, P Riekkinen.   

Abstract

The present experiment was designed to elucidate whether chronic dietary treatment with nimodipine (3 months, 1000 ppm) enhances water maze spatial navigation, passive avoidance behavior and locomotor activity, and whether such a treatment with nimodipine would interact with the therapeutic effect of acute metrifonate treatment. In young medial septum-lesioned rats, nimodipine had no effect by its own on cognitive or motor behavior, and did not enhance the water maze and passive avoidance behavior improving action of metrifonate (3 and 10 mg/kg. p.o.). Nimodipine treatment of aged rats did not markedly affect the deficit in motor performance. Single and combined nimodipine and metrifonate (3 and 10 mg/kg, p.o.) treatment of aged rats resulted in shorter escape distance values to the hidden water maze escape platform compared to those of control aged rats. The passive avoidance performance of aged rats was more effectively facilitated by a combined nimodipine and metrifonate treatment than by either of the drugs on their own. Following a washout period of 2.5 months the rats that were treated previously with nimodipine no longer performed better than aged controls in the water maze test. Furthermore, after the washout period metrifonate 10 mg/kg was no longer effective in improving the water maze behavior of the now 26-month-old rats irrespective of their chronic pretreatment. Taken together, these findings indicate that chronic nimodipine and acute metrifonate treatment may more effectively stimulate cognitive functioning than either of the treatments on their own.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9088863     DOI: 10.1016/s0014-2999(96)00976-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  11 in total

Review 1.  Dissecting the age-related decline on spatial learning and memory tasks in rodent models: N-methyl-D-aspartate receptors and voltage-dependent Ca2+ channels in senescent synaptic plasticity.

Authors:  Thomas C Foster
Journal:  Prog Neurobiol       Date:  2012-01-28       Impact factor: 11.685

Review 2.  Metrifonate.

Authors:  H M Lamb; D Faulds
Journal:  Drugs Aging       Date:  1997-12       Impact factor: 3.923

3.  Sex-dependent modulation of age-related cognitive decline by the L-type calcium channel gene Cacna1c (Cav 1.2).

Authors:  Panos Zanos; Shambhu Bhat; Chantelle E Terrillion; Robert J Smith; Leonardo H Tonelli; Todd D Gould
Journal:  Eur J Neurosci       Date:  2015-06-23       Impact factor: 3.386

4.  Impairment of L-type Ca2+ channel-dependent forms of hippocampal synaptic plasticity in mice deficient in the extracellular matrix glycoprotein tenascin-C.

Authors:  Matthias R Evers; Benedikt Salmen; Olena Bukalo; Astrid Rollenhagen; Michael R Bösl; Fabio Morellini; Udo Bartsch; Alexander Dityatev; Melitta Schachner
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

5.  A bout analysis reveals age-related methylmercury neurotoxicity and nimodipine neuroprotection.

Authors:  Andrew Nathanael Shen; Craig Cummings; Derek Pope; Daniel Hoffman; M Christopher Newland
Journal:  Behav Brain Res       Date:  2016-05-16       Impact factor: 3.332

6.  AR-R 17779 improves social recognition in rats by activation of nicotinic alpha7 receptors.

Authors:  Marja Van Kampen; Karin Selbach; Renate Schneider; Elleonore Schiegel; Frank Boess; Rudy Schreiber
Journal:  Psychopharmacology (Berl)       Date:  2004-01-15       Impact factor: 4.530

7.  Differential rescue of spatial memory deficits in aged rats by L-type voltage-dependent calcium channel and ryanodine receptor antagonism.

Authors:  S C Hopp; H M D'Angelo; S E Royer; R M Kaercher; L Adzovic; G L Wenk
Journal:  Neuroscience       Date:  2014-09-16       Impact factor: 3.590

Review 8.  Targeting microglia L-type voltage-dependent calcium channels for the treatment of central nervous system disorders.

Authors:  Sarah C Hopp
Journal:  J Neurosci Res       Date:  2020-01-29       Impact factor: 4.433

9.  The effects of rivastigmine plus selegiline on brain acetylcholinesterase, (Na, K)-, Mg-ATPase activities, antioxidant status, and learning performance of aged rats.

Authors:  Haris Carageorgiou; Antonios C Sideris; Ioanna Messari; Chrissoula I Liakou; Stylianos Tsakiris
Journal:  Neuropsychiatr Dis Treat       Date:  2008-08       Impact factor: 2.570

10.  Cross-disorder risk gene CACNA1C differentially modulates susceptibility to psychiatric disorders during development and adulthood.

Authors:  N Dedic; M L Pöhlmann; J S Richter; D Mehta; D Czamara; M W Metzger; J Dine; B T Bedenk; J Hartmann; K V Wagner; A Jurik; L M Almli; A Lori; S Moosmang; F Hofmann; C T Wotjak; G Rammes; M Eder; A Chen; K J Ressler; W Wurst; M V Schmidt; E B Binder; J M Deussing
Journal:  Mol Psychiatry       Date:  2017-07-11       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.